Literature DB >> 2965119

Microbiological properties of teicoplanin.

D Greenwood1.   

Abstract

Teicoplanin is a glycopeptide antibiotic structurally related to vancomycin. Both agents achieve their effect by binding to acyl-D-alanyl-D-alanine in the bacterial cell wall. The spectrum of activity of teicoplanin, like that of vancomycin, is restricted to Gram-positive aerobic and anaerobic bacteria. However, the activity of the two agents is not identical: teicoplanin is generally more active than vancomycin against streptococci and Gram-positive anaerobes; the two agents exhibit similar activity against Staphylococcus aureus (including methicillin-resistant strains); and vancomycin is more active than teicoplanin against some strains of coagulase-negative staphylococci. Inoculum size influences the activity of teicoplanin, and variations in activity against some strains of coagulase-negative staphylococci have been observed with different culture media. Resistance to teicoplanin and vancomycin is difficult to induce under laboratory conditions and the small increment in resistance that may develop is lost when the organisms are subcultured in the absence of the drugs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2965119     DOI: 10.1093/jac/21.suppl_a.1

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  30 in total

1.  Selective and differential medium for isolation of Bacteroides ureolyticus from clinical specimens.

Authors:  A Eley; T Clarry; K W Bennett
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

2.  High Heterogeneity of Multidrug-Resistant Enterobacteriaceae Fecal Levels in Hospitalized Patients Is Partially Driven by Intravenous β-Lactams.

Authors:  Eva M González-Barberá; Jaime Sanz; Ana Djukovic; Alejandro Artacho; Iván Peñaranda; Beatriz Herrera; María José Garzón; Miguel Salavert; José Luis López-Hontangas; Karina B Xavier; Bernhard Kuster; Laurent Debrauwer; Jean-Marc Rolain; Miguel A Sanz; Joao B Xavier; Carles Ubeda
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

3.  Regional prophylaxis with teicoplanin in monolateral or bilateral total knee replacement: an open study.

Authors:  F de Lalla; R Viola; G Pellizzer; L Lazzarini; A Tramarin; P Fabris
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

4.  Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection.

Authors:  W E Peetermans; J J Hoogeterp; A M Hazekamp-van Dokkum; P van den Broek; H Mattie
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

5.  Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci.

Authors:  F W Goldstein; A Coutrot; A Sieffer; J F Acar
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

6.  Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.

Authors:  M Lafaurie; B Perichon; A Lefort; C Carbon; P Courvalin; B Fantin
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

7.  Regional and systemic prophylaxis with teicoplanin in monolateral and bilateral total knee replacement procedures: study of pharmacokinetics and tissue penetration.

Authors:  F de Lalla; A Novelli; G Pellizzer; F Milocchi; R Viola; A Rigon; C Stecca; V Dal Pizzol; S Fallani; P Periti
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

Review 8.  Total Syntheses of Vancomycin-Related Glycopeptide Antibiotics and Key Analogues.

Authors:  Akinori Okano; Nicholas A Isley; Dale L Boger
Journal:  Chem Rev       Date:  2017-04-24       Impact factor: 60.622

Review 9.  Teicoplanin: 10 years of clinical experience.

Authors:  M Trautmann; H Wiedeck; M Ruhnke; M Oethinger; R Marre
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

10.  Mechanism of uptake of deglucoteicoplanin amide derivatives across outer membranes of Escherichia coli and Pseudomonas aeruginosa.

Authors:  R E Hancock; S W Farmer
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.